LivaNova (NasdaqGS:LIVN) Q4 2025 Earnings call February 25, 2026 08:00 AM ET Company ParticipantsAhmet Tezel - Chief Innovation OfficerAlex Shvartsburg - CFOAnthony Petrone - Managing Director and Equity ResearchBrianna Gotlin - Vice President of Investor RelationsJohn McAulay - Associate VPVladimir Makatsaria - CEOConference Call ParticipantsAdam Maeder - Managing Director and Senior Research AnalystBrett Fishman - VP and Senior Equity Research AnalystDavid Rescott - Senior Research AnalystMichael Polark - ...

Unisys (NYSE:UIS) Q4 2025 Earnings call February 25, 2026 08:00 AM ET Company ParticipantsDeb McCann - CFOMayank Tandon - Managing DirectorMichaela Pewarski - VP of Investor RelationsMike Thomson - CEO and PresidentRod Bourgeois - Managing Partner and Head of ResearchConference Call ParticipantsAna Goshko - Managing Director and Research AnalystAnja Soderstrom - Senior Equity Research AnalystMaggie Nolan - Research AnalystOperatorPlease note, this event is being recorded. I would now like to turn the confer ...

Reliance (NYSE:RS) Conference February 25, 2026 08:00 AM ET Company ParticipantsKarla Lewis - President and CEOConference Call ParticipantsKatja Jancic - Metals and Mining AnalystKatja JancicGood morning, everyone. This morning, we're starting with Reliance, and with us today is CEO, Karla Lewis. Karla, over to you.Karla LewisGood morning, everyone. Thanks for joining us today. Thank you to BMO and Katja for inviting Reliance to the conference. We're just gonna kick it off with a really quick overview of wh ...

Marker Therapeutics (NasdaqCM:MRKR) FY Conference February 25, 2026 08:00 AM ET Company ParticipantsAnthony - AssociateJuan Vera - President and CEOAnthonyGood morning, everyone, and thanks so much for joining us. I'm Anthony, an associate here at Oppenheimer, and it is my pleasure to introduce Marker Therapeutics. Marker is an immuno-oncology company focused on developing T-cell therapies using its multi-antigen recognizing or MAR-T platform. The lead program is MT-601, and it's being studied in relapse ly ...

Amarin Corporation (NasdaqCM:AMRN) Q4 2025 Earnings call February 25, 2026 08:00 AM ET Company ParticipantsAaron Berg - President and CEODevin Sullivan - VP of Investor RelationsPeter Fishman - CFOConference Call ParticipantsNone - AnalystNone - AnalystOperatorPlease note this conference is being recorded. I would now like to turn the conference call over to Devin Sullivan, Investor Relations for Amarin.Devin SullivanThank you for your time and attention this morning as we discuss Amarin's 2025 fourth quart ...

Turn Therapeutics (NasdaqGM:TTRX) FY Conference February 25, 2026 08:00 AM ET Company ParticipantsBradley Burnam - Founder and CEOBradley BurnamI'm going to just start us off here. I'm gonna thank Oppenheimer for inviting us to Turn. I'm going to thank Leland for introducing us, hearing himself again, I'm sure on echo was interesting, and I'm sure he'll be back on to moderate. Joining me is Zuraiz Chaudhary, our CFO, arguably one of the most brilliant financial experts I know, I'm Bradley Burnam, CEO, Found ...

HSBC (NYSE:HSBC) Q4 2025 Earnings call February 25, 2026 08:00 AM ET Company ParticipantsAlastair Ryan - Global Head of Investor RelationsDaniel David - Senior European Banks Credit Equity ResearchFaisal Yousaf - Group TreasurerGreg Case - Head of Fixed Income Investor RelationsLee Street - VP of Equity ResearchPaul Fenner-Leitao - Managing Director of Credits Equity ResearchFaisal YousafHello, everyone, and thank you for joining our full year 2025 fixed income investor call. I'm Faisal Yousaf, Group Treasu ...

LivaNova (NasdaqGS:LIVN) Q4 2025 Earnings call February 25, 2026 08:00 AM ET Company ParticipantsAhmet Tezel - Chief Innovation OfficerAlex Shvartsburg - CFOAnthony Petrone - Managing Director and Equity ResearchBrianna Gotlin - Vice President of Investor RelationsJohn McAulay - Associate VPVladimir Makatsaria - CEOConference Call ParticipantsAdam Maeder - Managing Director and Senior Research AnalystBrett Fishman - VP and Senior Equity Research AnalystDavid Rescott - Senior Research AnalystMichael Polark - ...

Alcon (NYSE:ALC) Q4 2025 Earnings call February 25, 2026 08:00 AM ET Company ParticipantsDan Cravens - Vice President and Head of Investor RelationsDavid Endicott - CEOGraham Doyle - Executive Director and Head of European MedTechIssie Kirby - VP of Equity ResearchPatrick Wood - Managing Director and Head of the U.S. Medical Technology Equity Research TeamTim Stonesifer - CFOTom Stephan - VP of Healthcare Equity ResearchVeronika Dubajova - Managing DirectorConference Call ParticipantsAnthony Petrone - Manag ...

Alkermes (NasdaqGS:ALKS) Q4 2025 Earnings call February 25, 2026 08:00 AM ET Company ParticipantsAmi Fadia - Managing DirectorAnya John - Research AssociateBlair Jackson - COODouglas Tsao - Managing DirectorIain Brown - CFOJoon Lee - Managing DirectorJoseph Thome - Managing DirectorJulian Pino - Biotechnology Equity ResearchRichard Pops - CEORudy Li - DirectorSandy Coombs - SVP of Investor Relations and Corporate AffairsTodd Nichols - Chief Commercial OfficerUmer Raffat - Senior Managing DirectorConference ...